Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report

BACKGROUND: Typhoid fever remains an important public health problem in developing countries and is endemic in many parts of Asia and Africa where the incidence of disease typically peaks in school-aged children. Age restrictions and other limitations of existing oral live-attenuated typhoid and par...

Descripción completa

Detalles Bibliográficos
Autores principales: Capeding, Maria Rosario, Alberto, Edison, Sil, Arijit, Saluja, Tarun, Teshome, Samuel, Kim, Deok Ryun, Park, Ju Yeon, Yang, Jae Seung, Chinaworapong, Suchada, Park, Jiwook, Jo, Sue-Kyoung, Chon, Yun, Yang, Seon-Young, Ham, Dong Soo, Ryu, Ji Hwa, Lynch, Julia, Kim, Jerome H., Kim, Hun, Excler, Jean-Louis, Wartel, T. Anh, Sahastrabuddhe, Sushant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273193/
https://www.ncbi.nlm.nih.gov/pubmed/31585725
http://dx.doi.org/10.1016/j.vaccine.2019.09.074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273193/
https://www.ncbi.nlm.nih.gov/pubmed/31585725
http://dx.doi.org/10.1016/j.vaccine.2019.09.074

Ejemplares similares